股票代码：******
网站地图
Jan 14,2022
Shenzhen Gaoxin Investment and Huayu Hengtai visit the institute for research
From November 26 to 30, 2021, a delegation of 7 people from Shenzhen Gaoxintou Group Co., Ltd. Talent Equity Investment Fund Management Co., Ltd. and 2 people from Shenzhen Huayuhengtai Commercial Factoring Co., Ltd., accompanied by the company's Vice Chairman Jing Yue, specially visited the company to conduct investment research. The company's investors and board representatives accompanied the research.
Dec 15,2021
Promote a win-win development cycle and integrate into the bridgehead of the Greater Bay Area
From November 26 to 30, 2021, a delegation of 7 people from Shenzhen Gaoxintou Group Co., Ltd. Talent Equity Investment Fund Management Co., Ltd. and 2 people from Shenzhen Huayuhengtai Commercial Factoring Co., Ltd., accompanied by the company's Vice Chairman Jing Yue, specially visited the company to conduct investment research. The company's investors and board representatives accompanied the research.
Feb 08,2021
On November 11, 2020, Zhou Yaohua, a member of the Party Leadership Group and second-level investigator of the Ji'an Association for Science and Technology, along with Han Runlin, a member of the Party Leadership Group and vice chairman, visited our company accompanied by Deputy Director Li Xiaoping of the Jingkai District Economic and Science Bureau to conduct an inspection of the enterprise's Association for Science and Technology and the Haizhi Program Workstation. General Manager Yao Xiao, Deputy General Manager Liu Xiaoan, and Lai Ruohong accompanied the inspection team and provided a detailed introduction to the construction of the company's Association for Science and Technology and Haizhi Program Workstation. In May 2020, the company applied to the Ji'an Association for Science and Technology for the Haizhi Program Workstation, establishing a platform to expand exchanges and cooperation with overseas experts, teams, and research institutions, which was recognized and supported by the Ji'an Association for Science and Technology.
General Manager Yao Xiaodong introduced the company's use of the Haizhi Program Workstation platform to proactively engage internationally, conducting in-depth cooperation with foreign academicians and expert teams from universities to promote the company's major development in scientific research and technology. Relying on the Haizhi Program Workstation, the company actively connects with the Ji'an Association for Science and Technology's talent introduction plan, hiring Dr. Shen Guangfu from the David Geffen School of Medicine at the University of California, Los Angeles, for joint development of new antitoxin products; and introducing the lifelong academician Gustavo's expert team from Cuba to jointly research and create a new generation of vaccines, adjuvants, and immune enhancers. Deputy General Manager Liu Xiaoan introduced the operation of the company's Association for Science and Technology and Haizhi Program Workstation platform and the progress of overseas research and development cooperation projects. To better promote the company's innovation strategy development, the company's Association for Science and Technology has successively established the Jiangsheng (Shenzhen) Biotechnology Research and Development Center based on the Haizhi Program Workstation and acquired the Hainan Provincial Institute of Pharmaceutical Research, which has innovative research and incubation platforms, providing new technical support and innovation momentum for the company's sustainable development. Deputy General Manager Lai Ruohong emphasized the company's active use of foreign talents' expertise to cultivate outward-oriented talents needed by the enterprise, providing better support for the Association for Science and Technology and Haizhi Program Workstation. On one hand, this expands the company's professional talent knowledge base; on the other hand, it increases opportunities for talent learning and exchange, meeting the company's research and development technology development needs and promoting innovative research and development.
After carefully listening to the company's Haizhi Program Workstation situation, the Ji'an Association for Science and Technology inspection team affirmed the talent teams introduced by the company's Haizhi Program Workstation and the subsequent cooperation and exchange methods. They expect the enterprise to rely on the Haizhi Program Workstation platform to provide a solid backing for the company's technological innovation and achievement transformation. They also advocate that enterprises actively go out to strengthen exchanges and interactions on talent platforms. By leveraging academician expert teams, they aim to strengthen internal talent cultivation and plan clear promotion channels for scientific research talents. They also encouraged the company to carefully study talent policy-related documents, strengthen investment in research and development innovation and talent introduction and cultivation, and enhance the development of external cooperation projects. They urged alignment with relevant government incentive policies to implement projects and policies effectively.
Feb 08,2021
On November 11, 2020, to implement the spirit of the "Feedback on the Quality Inspection of Jiangxi Enterprise R&D Statistical Annual Report Data" issued by the Social Science and Culture Department of the National Bureau of Statistics, and to effectively improve the quality of our province's R&D statistical data, Director Wan from Jiangxi Provincial Bureau of Statistics and Director Liu Jizhong from the Economic Development Bureau, along with their team, visited our company to conduct the 2019 enterprise R&D statistical data inspection. The inspection team listened to reports on enterprise development and R&D progress, learning that the company's development goal is to focus on animal immunoglobulin preparations, aiming to become a leading global supplier of major animal immune serum products with a high international market position. The company strives to dominate the market, lead in technology, share platforms in the field of immune drugs and therapies, and become one of the most valuable and competitive modern export-oriented biopharmaceutical enterprises worldwide.
General Manager Yao Xiaodong stated that the company attaches great importance to R&D and actively establishes domestic and international scientific research platforms. To meet the needs of domestic biotechnology development, the company plans comprehensively to promote innovation and R&D, driving the company's innovation strategy development. It has successively established Jiangsheng (Shenzhen) Biotechnology R&D Center and acquired the Hainan Institute of Pharmaceutical Research, providing technical support and innovation momentum for the company's sustainable development. Subsequently, the inspection team conducted a detailed verification of the enterprise's R&D statistical annual report data. Enterprise science and technology statisticians, research management personnel, and financial staff conducted on-site verification of the annual report data submission. The inspection team thoroughly compared the completeness of the data and communicated face-to-face with relevant enterprise personnel to ensure data accuracy. After checking and verification, Director Wan from Jiangxi Provincial Bureau of Statistics highly praised the company's R&D data submission. The company attaches great importance to the submission of R&D statistical data, with each item of R&D data being truthful and the quality of R&D statistical data being high.
Add:
Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China
Board Office:
Complaint & Report Hotline:
Pharmacovigilance Hotline:
Company Email:
Investor Relations:
International Sales Email:
Complaint/Report Email:
WeChat mini-site
WeChat official account
© Copyright 2025 Jiangxi Institute of Biological Products Inc. | SEO
Business License
Powered by www.300.cn